-
Subject Areas on Research
-
A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder.
-
Adjunctive Maintenance Lamotrigine for Pediatric Bipolar I Disorder: A Placebo-Controlled, Randomized Withdrawal Study.
-
Adjunctive lamotrigine for partial seizures in patients aged 1 to 24 months.
-
Bidirectional interaction of valproate and lamotrigine in healthy subjects.
-
Case report: Successful riluzole augmentation therapy in treatment-resistant bipolar depression following the development of rash with lamotrigine.
-
Clinical characteristics of antiepileptic-induced liver injury in patients from the DILIN prospective study.
-
Comments on "Addition of lamotrigine to valproic acid: a successful outcome in a case of rapid-cycling bipolar affective disorder".
-
Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese.
-
Comparison of brand versus generic antiepileptic drug adverse event reporting rates in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS).
-
Derivation of the SPAN, a brief diagnostic screening test for post-traumatic stress disorder.
-
Discovery and development of lamotrigine for bipolar disorder: a story of serendipity, clinical observations, risk taking, and persistence.
-
Dramatic Response After Lamotrigine in a Patient With Epileptic Encephalopathy and a De NovoCACNA1A Variant.
-
Efficacy, tolerability, and kinetics of lamotrigine in infants.
-
Genome-wide mapping for clinically relevant predictors of lamotrigine- and phenytoin-induced hypersensitivity reactions.
-
Improved sexual function in three men taking lamotrigine for epilepsy.
-
Increased Antiseizure Effectiveness with Tiagabine Combined with Sodium Channel Antagonists in Mice Exposed to Hyperbaric Oxygen.
-
Lamotrigine as add-on therapy in schizophrenia: results of 2 placebo-controlled trials.
-
Lamotrigine for bipolar disorder and comorbid cocaine dependence: a replication and extension study.
-
Lamotrigine in absence and primary generalized epilepsies.
-
Lamotrigine-induced blepharospasm.
-
Long-term tolerability and efficacy of lamotrigine in infants 1 to 24 months old.
-
Long-term tolerability, pharmacokinetic and preliminary efficacy study of lamotrigine in patients with resistant partial seizures.
-
Motor cortex excitability after vagus nerve stimulation in major depression.
-
Oculogyric crises secondary to lamotrigine overdosage.
-
Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. U.S. Lamotrigine Protocol 0.5 Clinical Trial Group.
-
Potential hepatotoxicity of lamotrigine.
-
Routine therapeutic monitoring of lamotrigine in epileptic patients using a simple and rapid high performance liquid chromatographic technique.
-
The name game: lamivudine-lamotrigine dispensing error presenting as human immunodeficiency virus-associated fever of unknown origin.
-
Use of Therapeutic Drug Monitoring, Electronic Health Record Data, and Pharmacokinetic Modeling to Determine the Therapeutic Index of Phenytoin and Lamotrigine.
-
Use of lamotrigine in a patient with a clozapine-related seizure.